UBS Group’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.29M | Sell |
182,456
-53,501
| -23% | -$2.72M | ﹤0.01% | 2472 |
|
|
2025
Q1 | $10.6M | Buy |
235,957
+51,368
| +28% | +$2.31M | ﹤0.01% | 2305 |
|
|
2024
Q4 | $7.63M | Buy |
184,589
+60,199
| +48% | +$2.49M | ﹤0.01% | 2597 |
|
|
2024
Q3 | $4.85M | Buy |
124,390
+73,647
| +145% | +$2.87M | ﹤0.01% | 2299 |
|
|
2024
Q2 | $1.73M | Sell |
50,743
-106,168
| -68% | -$3.63M | ﹤0.01% | 2965 |
|
|
2024
Q1 | $3.94M | Buy |
156,911
+38,370
| +32% | +$964K | ﹤0.01% | 2397 |
|
|
2023
Q4 | $3.5M | Buy |
118,541
+118,348
| +61,320% | +$3.49M | ﹤0.01% | 2319 |
|
|
2023
Q3 | $6.1K | Sell |
193
-110,453
| -100% | -$3.49M | ﹤0.01% | 6180 |
|
|
2023
Q2 | $2.86M | Buy |
110,646
+70,080
| +173% | +$1.81M | ﹤0.01% | 2379 |
|
|
2023
Q1 | $974K | Sell |
40,566
-66,550
| -62% | -$1.6M | ﹤0.01% | 3194 |
|
|
2022
Q4 | $2.09M | Buy |
107,116
+89,139
| +496% | +$1.74M | ﹤0.01% | 2533 |
|
|
2022
Q3 | $378K | Buy |
+17,977
| New | +$378K | ﹤0.01% | 3595 |
|
|
2022
Q1 | – | Sell |
-2,481
| Closed | -$39K | – | 9429 |
|
|
2021
Q4 | $39K | Buy |
2,481
+1,727
| +229% | +$27.1K | ﹤0.01% | 6047 |
|
|
2021
Q3 | $15K | Buy |
+754
| New | +$15K | ﹤0.01% | 6364 |
|
|
2021
Q2 | – | Sell |
-1,161
| Closed | -$23K | – | 8447 |
|
|
2021
Q1 | $23K | Sell |
1,161
-13,393
| -92% | -$265K | ﹤0.01% | 6225 |
|
|
2020
Q4 | $254K | Buy |
14,554
+205
| +1% | +$3.58K | ﹤0.01% | 4132 |
|
|
2020
Q3 | $277K | Sell |
14,349
-1,448
| -9% | -$28K | ﹤0.01% | 3799 |
|
|
2020
Q2 | $307K | Sell |
15,797
-1,203
| -7% | -$23.4K | ﹤0.01% | 3719 |
|
|
2020
Q1 | $238K | Buy |
17,000
+12,183
| +253% | +$171K | ﹤0.01% | 3769 |
|
|
2019
Q4 | $118K | Buy |
4,817
+1,229
| +34% | +$30.1K | ﹤0.01% | 4892 |
|
|
2019
Q3 | $36K | Buy |
+3,588
| New | +$36K | ﹤0.01% | 5425 |
|